Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
md_biochemistry [2026/02/20 09:30] resident |
md_biochemistry [2026/02/27 05:02] (current) resident |
||
|---|---|---|---|
| Line 44: | Line 44: | ||
| |31|:::| | | |31|:::| | | ||
| |24|< | |24|< | ||
| - | |25|::: | + | |25|::: |
| - | |26|:::| | | + | |26|:::|Tertery & Quaternary Protein structure |{{ : |
| - | |27|:::| | | + | |27|:::|Arginine Metabolism|{{ :: |
| - | |28|:::| | | + | |28|:::|Hartnup disease|{{ :: |
| - | |29|:::| | | + | |29|:::|IQC|{{ :: |
| |30|:::| | | |30|:::| | | ||
| |31|:::| | | |31|:::| | | ||
| Line 321: | Line 321: | ||
| - Tocilizumab | - Tocilizumab | ||
| - Hydroxychloroquine | - Hydroxychloroquine | ||
| + | - Rifaximin | ||